Caliway Biopharmaceuticals
6919.TW
#3104
Rank
NZ$8.80 B
Marketcap
NZ$5.65
Share price
2.46%
Change (1 day)
14.46%
Change (1 year)

Revenue for Caliway Biopharmaceuticals (6919.TW)

Revenue in 2025 (TTM): NZ$2.13 Million

According to Caliway Biopharmaceuticals's latest financial reports the company's current revenue (TTM ) is NZ$2.14 Million. a decrease over the revenue in the year 2024 that were of NZ$2.46 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Caliway Biopharmaceuticals from 2023 to 2025

Annual revenue

Year Revenue Change
2025 NZ$2.16 M-11.87%
2024 NZ$2.46 M24.5%
2023 NZ$1.97 M